Vol 8, No 6 (2019)

Date published: 2020-01-24

Table of Contents

open access

ORIGINAL ARTICLES

The effect of linagliptin treatment on gut microbiota in patients with HNF1A-MODY or type 2 diabetes — a preliminary cohort study

Sandra Mrozinska, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, Magdalena Szopa, Małgorzata Bulanda, Maciej T Malecki, Tomasz Klupa

DOI: 10.5603/DK.2019.0024
Clinical Diabetology 2019;8(6):263-270.

Role of serum allograft inflammatory factor-1 (AIF-1) in Egyptian type 2 diabetic patients

Mona Kamal ElDeeb, Gihane Ibrahim Khalil, Moatez Ahmed Zaki, El-Sayed Mehana, Sahar Omer

DOI: 10.5603/DK.2019.0025
Clinical Diabetology 2019;8(6):271-276.

Correlations between biomarkers of oxidative stress, glycemic control and insulin resistance in women with type 2 diabetes

Ali Khosrowbeygi, Mahsa Gholami, Parvin Zarei, Bahman Sadeghi Sedeh, Mohammad Reza Rezvanfar, Mohammad Reza Rezvanfar

DOI: 10.5603/DK.2019.0026
Clinical Diabetology 2019;8(6):277-283.

A case study of eight type 2 diabetic stage 4 chronic kidney disease patients showing lower glycemic variability with faster-acting insulin aspart as compared to insulin aspart

Sayak Roy, Camelia Biswas, Mridul Bera, Guruprasad Bhattacharya

DOI: 10.5603/DK.2019.0027
Clinical Diabetology 2019;8(6):284-291.

Health care seeking behaviors in type 2 diabetic patients in East Azerbaijan

Habib Jalilian, Mohammad Zakaria Pezeshki, Leila Torkzadeh, Elnaz Javanshir, Ahmad Moradi, Rahim Khodayari Zarnaq

DOI: 10.5603/DK.2019.0031
Clinical Diabetology 2019;8(6):292-302.
REVIEW ARTICLES

Review of nuclear medicine methods applied in diabetology

Paulina Cegła, Dorota Pisarczyk-Wiza, Krzysztof Matuszewski, Kamila Witkowska, Natalia Bocer, Katarzyna Pietrasz, Aleksandra Kaczmarek, Dorota Zozulińska-Ziółkiewicz

DOI: 10.5603/DK.2019.0028
Clinical Diabetology 2019;8(6):303-309.
Pharmaceutical news

Experts opinion: implantable continuous glucose monitoring system — innovation in the management of diabetes

Agnieszka Szadkowska, Dorota Zozulińska-Ziółkiewicz, Mieczysław Walczak, Katarzyna Cyganek, Bogumił Wolnik, Andrzej Gawrecki, Małgorzata Myśliwiec

DOI: 10.5603/DK.2019.0030
Clinical Diabetology 2019;8(6):318-328.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl